Approving Last of Two Genes, FDA Finally Clears Roche s AmpliChip as an IVD | GenomeWeb

NEW YORK, Jan. 11 (GenomeWeb News) - The US Food and Drug Administration has cleared the second of two genes in Roche Diagnostic's AmpliChip CYP450 test, clearing the way for the device to be sold as an in vitro diagnostic in the United States, the company said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.